These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction. Schinkel AF; Bax JJ; Sozzi FB; Boersma E; Valkema R; Elhendy A; Roelandt JR; Poldermans D Heart; 2002 Aug; 88(2):125-30. PubMed ID: 12117829 [TBL] [Abstract][Full Text] [Related]
8. Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value. Tian Y; Zhao M; Li W; Zhu Z; Mi H; Li X; Zhang X Int J Cardiovasc Imaging; 2020 Oct; 36(10):2063-2071. PubMed ID: 32495064 [TBL] [Abstract][Full Text] [Related]
9. Rest-redistribution 201-Thallium single photon emission computed tomography predicts myocardial infarction and cardiac death in patients with ischemic left ventricular dysfunction. Perrone-Filardi P; Pace L; Dellegrottaglie S; Corrado L; Prastaro M; Cafiero M; Caiazzo G; Marzano A; Cesarano P; Gargiulo P; Paolillo S; Maglione A; Petretta A; Chiariello M J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):122-8. PubMed ID: 19377379 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Myocardial Viability in Ischemic Cardiomyopathy With Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting. Arjomandi Rad A; Tserioti E; Magouliotis DE; Vardanyan R; Samiotis IV; Skoularigis J; Ariff B; Xanthopoulos A; Triposkiadis F; Casula R; Athanasiou T Clin Cardiol; 2024 Jul; 47(7):e24307. PubMed ID: 38953367 [TBL] [Abstract][Full Text] [Related]
11. Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease. Mc Ardle B; Shukla T; Nichol G; deKemp RA; Bernick J; Guo A; Lim SP; Davies RA; Haddad H; Duchesne L; Hendry P; Masters R; Ross H; Freeman M; Gulenchyn K; Racine N; Humen D; Benard F; Ruddy TD; Chow BJ; Mielniczuk L; DaSilva JN; Garrard L; Wells GA; Beanlands RS; Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27609816 [TBL] [Abstract][Full Text] [Related]
12. Electrocardiographically concealed variation in left ventricular capture: a case with implications for resynchronization therapy in ischemic cardiomyopathy. Grimley SR; Suffoletto MS; Gorcsan J; Schwartzman D Heart Rhythm; 2006 Jun; 3(6):739-42. PubMed ID: 16731481 [No Abstract] [Full Text] [Related]
13. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons. Ogawa M; Doi K; Fukumoto A; Yaku H Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization. Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865 [TBL] [Abstract][Full Text] [Related]
15. Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability. Schinkel AF; Bax JJ; Biagini E; Elhendy A; van Domburg RT; Valkema R; Rizzello V; Schouten O; Simoons M; Poldermans D Am J Cardiol; 2005 May; 95(10):1223-5. PubMed ID: 15877995 [TBL] [Abstract][Full Text] [Related]
16. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888 [TBL] [Abstract][Full Text] [Related]
17. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction. Schneider CA; Voth E; Baer FM; Horst M; Wagner R; Sechtem U Circulation; 1997 Dec; 96(11):3913-20. PubMed ID: 9403615 [TBL] [Abstract][Full Text] [Related]
18. Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy. Samady H; Liu YH; Choi CJ; Ragosta M; Pfau SE; Cleman MW; Powers ER; Kramer CM; Wackers FJ; Beller GA; Watson DD Am J Cardiol; 2003 Apr; 91(7):807-11. PubMed ID: 12667565 [TBL] [Abstract][Full Text] [Related]
19. Myocardial contrast echocardiography in chronic ischemic and nonischemic cardiomyopathies. Monakier D; Woo A; Vannan MA; Rakowski H Cardiol Clin; 2004 May; 22(2):269-82. PubMed ID: 15158939 [TBL] [Abstract][Full Text] [Related]
20. Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial. Mahmarian JJ; Cerqueira MD; Iskandrian AE; Bateman TM; Thomas GS; Hendel RC; Moye LA; Olmsted AW JACC Cardiovasc Imaging; 2009 Aug; 2(8):959-68. PubMed ID: 19679284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]